Text Size
2 studies found for:    20122739 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Efficacy and Safety Trial of Intravitreal Injections Combined With PRP for the Treatment of CSME Secondary to Diabetes Mellitus (DAVE)
Condition: Diabetic Macular Edema
Interventions: Drug: 0.30mg ranibizumab;   Procedure: Targeted Pan Retinal Photocoagulation
2 Completed
Has Results 		Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema
Condition: Diabetic Macular Edema
Interventions: Procedure: Standard of Care Group;   Drug: 1mg triamcinolone acetonide;   Drug: 4mg triamcinolone acetonide
To Top

† Indicates status has not been verified in more than two years